sclerostin inhibitor Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Unknown (1)

Observational (1)

Yeungnam University Hospital (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadosteoporosis

I am/have/hadspinal cord disorder

I am/have/hadinjuries

I am/have/hadsclerostin

I am/have/hadspinal cord injury

added new label for I am/have/had

more

I am looking for

I am looking forromosozumab

I am looking forsclerostin inhibitor

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For Seniors
For adults
Recruiting in 10s
Observational Study
all
Dermatology
Recruiting

Bone-biomarkers of Spinal Cord Injury Patients

Recently, various treatment drugs for osteoporosis have been developed. In particular, romosozumab, a sclerostin inhibitor, has been reported to have a high therapeutic effect as an inhibitor of bone resorption while promoting bone formation. However, there are a few research concerning sclerostin of spinal cord injuries patients.

osteoporosis

spinal cord disorder

injuries

romosozumab

sclerostin inhibitor

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2026 All rights reserved.